Viewing StudyNCT00012064



Ignite Creation Date: 2024-05-05 @ 11:23 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00012064
Status: COMPLETED
Last Update Posted: 2014-01-29
First Post: 2001-03-03

Brief Title: Vaccine Therapy in Treating Patients With Stage IV or Recurrent Melanoma
Sponsor: Lisata Therapeutics Inc
Organization: Lisata Therapeutics Inc

Conditions & Keywords Data

Conditions:
Name
Melanoma Skin
Keywords:
Name View
recurrent melanoma View
stage IV melanoma View